{"name":"Theranica","slug":"theranica","ticker":"","exchange":"","domain":"theranica.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Migraine Relief","genericName":"Migraine Relief","slug":"migraine-relief","indication":"Migraine prevention","status":"marketed"}]}],"pipeline":[{"name":"Migraine Relief","genericName":"Migraine Relief","slug":"migraine-relief","phase":"marketed","mechanism":"Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches.","indications":["Migraine prevention","Acute migraine treatment"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxPZlBMT2d1QUVld21lU3BKSTZSUjF0R1hSVGtGalUzOU1iZzYxSVdwNEdKcF9iVm1JSW00M2QzQWZwZXZWMllGV045eE9HQ194OVRNYm9CNW1VMFN1dGV0ODA3T1drYnFXSWVCcmF5X1lSSHk3SnAtY01Ia2FwVXg1blpzODJhMi1TS1RCMDlwNlIzODBBRFZxOTRSSE1lbE1lRklvajRVTVlON3FoWDcwMWhLcmJaSXJJXzc0cEd0T0lqOTNkeXRUaGMyMkFmVFkwSVdVNWF4T3BNRVhXbU9hczVrakpOV0w5WlRRS0dxMGRKZXNLWjdkNnQtejVvdExBYlM2dnRjS2ppSExlZ0tWZmpxLXdGTE93SE1FVGZZMA?oc=5","date":"2024-04-10","type":"pipeline","source":"STT Info","summary":"Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment | Reddy's Laboratories SA - STT Info","headline":"Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPSTZzYmdGUVh1WEYzS1E3dWxqRXRNdGhLbDJaOHpJbzBWbUNLVzFWTEwyX1VoVDhUMkxkaEZrRFByWnU1ZjBMNXZkbmgybUJ2N3ZJdDF6MG1ZbjQ5R2xJbVVZb25Wc2kyc0xzQUxKSVppY3VlblFsVGlldERQUGRPcE0wZG5nVnA2UE13aTZOaEtpdms0OWpTQ213REJqQkNWWGdMbnJMQmFkYjA?oc=5","date":"2023-08-10","type":"pipeline","source":"BioWorld News","summary":"Theranica’s Nerivio to bring relief to migraine sufferers in Europe - BioWorld News","headline":"Theranica’s Nerivio to bring relief to migraine sufferers in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQOFhtUFd4QlAwektkdlJVZEZBM2dFdWJWQk9SVFJ5M19QNjJOZW84RWxJc241S1hKbUV5b3cyYW9DVjQ3bjdtZW1XOVJUZVhnWEhvNUF0QkJEMnpSdEp6eW5tSHRKa0o2cDI3N1FlNkZ6M1ljYzVOT2tWMXYtdnVDOU1uOHk0d0dpQThEa19wU0t5dFNYUS1ic3loYUhvb0tGQVk0UFBYa2RvQTJhOEtDdU9yQVlxUWVLdnU3eXJDNmkxVld5M1E?oc=5","date":"2022-10-18","type":"regulatory","source":"Fierce Biotech","summary":"Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment - Fierce Biotech","headline":"Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOQ0doNkZ2b25mU1BVS1pORGk4OVhUY2RkZ0RxM3N3THdETTlRcGprQ2l5dThhNGlQOW52NjRyRU01eDloVV8xRHNpZWJjS2hGWW1tZldHMDZGaWducHZfRDlRMll3emxxODNEdGRsc0ZTdks5ZGY4Vk9FTVNwcGFlOE1ySkNBcS1KalVNd2Q5dnJNVldQdjJ0Wk8yQm9MZw?oc=5","date":"2022-08-30","type":"pipeline","source":"NeuroNews International","summary":"Theranica secures US$45 million through Series C funding round - NeuroNews International","headline":"Theranica secures US$45 million through Series C funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPay13Ynlybm5wYXhXa0taaGFOOVdYRE9BTzFtNTcxUUVlOWt2dWJVck85MlNVTEI3RDYxUlRTSno5ZTNCNXlSaEhLR3hhbUVROTVJUHl3czF6R0JEN1NuUUR2dHl0VDRLMXlyXzV6UnM3T2YzR25wQUUwZHpaMTZFY09pZkY1d1hHcWpHb1NxQ0tQTFdseUxHaElzV09Fc0lqcUx6a3Jwbkl4Zw?oc=5","date":"2022-08-30","type":"pipeline","source":"Fierce Biotech","summary":"Theranica ropes in $45M for smartphone-connected migraine modulation armband - Fierce Biotech","headline":"Theranica ropes in $45M for smartphone-connected migraine modulation armband","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5TbFdSMXY0ci1OSW44Z0U3QTNSU1kxSFAtQjl1NkNHVDhRS0trNFppbGtkVWVDcnJGbnJYV180Y0Y1TWNwTzNaV2FsajA1dlNScnhCVG1QZ21keXdSckFtV0I1R1hqeExsTHc?oc=5","date":"2021-11-25","type":"pipeline","source":"Health Tech World","summary":"Interview: The drug-free migraine treatment that’s got big pharma worried - Health Tech World","headline":"Interview: The drug-free migraine treatment that’s got big pharma worried","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPRkZhSm45OFpmVGc2bnJ2SkhHbjVwSWhKQ1pFVGNDN1hGclhZR1lxQ096aDN4bE9Sc3RwZXpsbVU2ZTJwSE90b2dBUUlURUFIeUlMbnpheE1YT284VjU1REs5aEFBQ1FhQ0RSRFhTZ2M2Z3F4RHRJSnZWZzdrSldwM1R1M3VVcC16NjZQRWxMSEdFNFdkVXZDWFlsT3pnaGVQeEtoRkxlVFowLS14alVLT3ZnaFdUMmhfWERKT3dOczMwdFRQS3Mzc3J3?oc=5","date":"2021-10-25","type":"trial","source":"The Jerusalem Post","summary":"US study shows Israeli device effective against chronic migraines - The Jerusalem Post","headline":"US study shows Israeli device effective against chronic migraines","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}